Atara Biotherapeutics

(NASDAQ) ATRA

Current Price$9.47

Market Cap$86.32M

Since IPO (2014)-97%

5 Year-97%

1 Year+26%

1 Month+83%

Atara Biotherapeutics Financials at a Glance

Market Cap

$86.32M

Revenue (TTM)

$23.14M

Net Income (TTM)

$9.47M

EPS (TTM)

$-0.88

P/E Ratio

-10.85

Dividend

$0.00

Beta (Volatility)

2.17 (High)

Dividend

$0.00

Beta (Volatility)

2.17 (High)

Price

$9.47

Volume

3,662

Open

$9.54

Price

$9.47

Volume

3,662

Open

$9.54

Previous Close

$9.47

Daily Range

$8.67 - $9.56

52-Week Range

$3.92 - $19.14

Dividend

$0.00

Beta (Volatility)

2.17 (High)

Price

$9.47

Volume

3,662

Open

$9.54

Previous Close

$9.47

Daily Range

$8.67 - $9.56

52-Week Range

$3.92 - $19.14

ATRA News

Page 1

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Atara Biotherapeutics

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Anhco Nguyen, PhD

Website

www.atarabio.com

Headquarters

South San Francisco, CA 94080, US

ATRA Financials

Key Financial Metrics (TTM)

Gross Margin

96%

Operating Margin

-27%

Net Income Margin

-41%

Return on Equity

Return on Capital

-44%

Return on Assets

-47%

Earnings Yield

-9.22%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$86.32M

Shares Outstanding

9.01M

Volume

3.66K

Avg. Volume

1.54M

Financials (TTM)

Gross Profit

$99.56M

Operating Income

$35.86M

EBITDA

$38.63M

Operating Cash Flow

$50.94M

Capital Expenditure

$0.00

Free Cash Flow

$50.94M

Cash & ST Invst.

$8.48M

Total Debt

$52.80M

Atara Biotherapeutics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$516.00K

-99.5%

Gross Profit

$392.00K

-99.5%

Gross Margin

75.97%

N/A

Market Cap

$86.32M

N/A

Market Cap/Employee

$564.17K

N/A

Employees

153

N/A

Net Income

$4.14M

-110.9%

EBITDA

$3.34M

-108.2%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Net Cash

$716.00K

+98.3%

Accounts Receivable

$0.00

-100.0%

Inventory

$0.00

N/A

Long Term Debt

$9.08M

-66.0%

Short Term Debt

$0.00

-100.0%

Return on Assets

-47.34%

N/A

Return on Invested Capital

-43.96%

N/A

Free Cash Flow

$3.07M

+89.1%

Operating Cash Flow

$3.07M

+89.1%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

CSBRChampions Oncology, Inc.

CSBRChampions Oncology, Inc.$6.20-0.16%

COYACoya Therapeutics, Inc.

COYACoya Therapeutics, Inc.$4.96-5.70%

CLNNClene Inc.

CLNNClene Inc.$7.14+1.28%

IFRXInflaRx N.V.

IFRXInflaRx N.V.$2.47+3.78%

ORMPOramed Pharmaceuticals Inc.

ORMPOramed Pharmaceuticals Inc.$4.64-1.90%

CNTXContext Therapeutics Inc.

CNTXContext Therapeutics Inc.$2.16-7.30%

MGNXMacroGenics, Inc.

MGNXMacroGenics, Inc.$4.25+2.16%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NOKNokia

NOKNokia$13.95-0.04%

FFord Motor Company

FFord Motor Company$13.40-0.07%

POETPoet Technologies

POETPoet Technologies$15.97-0.22%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$15.06-0.10%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$75.34-0.05%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$42.98+0.05%

PIIIP3 Health Partners

PIIIP3 Health Partners$11.29+1.80%

Questions About ATRA

What is the current price of Atara Biotherapeutics?

Atara Biotherapeutics is trading at $9.47 per share.

What is the 52-week range for Atara Biotherapeutics?

Over the past 52 weeks, Atara Biotherapeutics has traded between $3.92 and $19.15.

How much debt does Atara Biotherapeutics have?

As of the most recent reporting period, Atara Biotherapeutics reported total debt of $51.56M.

How much cash does Atara Biotherapeutics have on hand?

Atara Biotherapeutics reported $8.36M in cash and cash equivalents in its most recent financial results.

What is Atara Biotherapeutics’s dividend yield?

Atara Biotherapeutics does not currently have a dividend yield.

Atara Biotherapeutics

Atara Biotherapeutics Financials at a Glance

ATRA News

Why Atara Biotherapeutics Stock Is Crashing Today

Why Atara Biotherapeutics Stock Is Sinking Today

2 Steps to Biotech Success: Good Data, Then Raise Capital

2 Biotech Stocks That Could Soar in 2020

2 Top Biotech Stocks Under $10

2 Incredibly Cheap Cancer Stocks to Buy Now

Why Atara Biotherapeutics Has Slumped in 2019

Why Atara Biotherapeutics Stock Is Imploding Today

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Atara Biotherapeutics

ATRA Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Atara Biotherapeutics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About ATRA

What is the current price of Atara Biotherapeutics?

What is the 52-week range for Atara Biotherapeutics?

How much debt does Atara Biotherapeutics have?

How much cash does Atara Biotherapeutics have on hand?

What is Atara Biotherapeutics’s dividend yield?

Premium Investing Services